Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
Two articles and an associated editorial, currently in press in the Journal of Urology, offer insight into the pre-treatment expectations and the post-treatment realities of men who decide to have surgical treatment for localized prostate cancer.
Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: decision-making, expectation, outcome, surgery | 4 Comments »
As many in the prostate cancer community will be aware, there has been a major battle ongoing over whether the drug bevacizumab (Avastin) should continue to be approved by the U.S. Food & Drug Administration (FDA) for the treatment of women with metastatic breast cancer.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: Centers for Medicare and Medicaid Services, CMS, coverage, off-label | Leave a Comment »
One of our regular correspondents has brought to our attention a recent article on the CureToday.com web site that deals with dating and cancer (with prostate cancer being a specific example referred to in the article).
Filed under: Living with Prostate Cancer | Tagged: conversation, dating, experience, sexual function | Leave a Comment »
Prostate cancer patients are commonly concerned about the potential risks for side effects associated with adjuvant and salvage radiation therapy after a preceding, first-line, radical prostatectomy.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: IMRT, intensity-modulated, prostate bed, radiation, side effect, toxicity, whole pelvis | 2 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site